Bioversys Ag
Clinical trials sponsored by Bioversys Ag, explained in plain language.
-
Brain TB breakthrough? new drug combo enters human testing
Disease control Not yet recruitingThis study is testing a new two-drug combination called Alpibectir/Ethionamide for tuberculosis meningitis, a serious brain infection. Researchers will measure how much of these drugs reach the brain fluid and check their safety in 64 newly diagnosed patients. The trial also aims…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Fighting the superbug: new hope for patients with untreatable infections
Disease control Not yet recruitingThis study is testing a new antibiotic combination called BV100 for patients with severe hospital-acquired infections caused by a dangerous, drug-resistant bacteria. It will compare BV100 combined with other antibiotics against the current best available treatments. The goal is t…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC